Le Bouc Raphaël, Rigoux Lionel, Schmidt Liane, Degos Bertrand, Welter Marie-Laure, Vidailhet Marie, Daunizeau Jean, Pessiglione Mathias
Motivation, Brain and Behavior Team, Institut du cerveau et de la Moelle Epinière, INSERM UMR1127, CNRS UMR 7225, Université Pierre et Marie Curie-Paris 6, Urgences cérébro-vasculaires, and.
Motivation, Brain and Behavior Team, Institut du cerveau et de la Moelle Epinière, INSERM UMR1127, CNRS UMR 7225, Université Pierre et Marie Curie-Paris 6.
J Neurosci. 2016 Jun 22;36(25):6623-33. doi: 10.1523/JNEUROSCI.3078-15.2016.
Motor dysfunction (e.g., bradykinesia) and motivational deficit (i.e., apathy) are hallmarks of Parkinson's disease (PD). Yet, it remains unclear whether these two symptoms arise from a same dopaminergic dysfunction. Here, we develop a computational model that articulates motor control to economic decision theory, to dissect the motor and motivational functions of dopamine in humans. This model can capture different aspects of the behavior: choice (which action is selected) and vigor (action speed and intensity). It was used to characterize the behavior of 24 PD patients, tested both when medicated and unmedicated, in two behavioral tasks: an incentive motivation task that involved producing a physical effort, knowing that it would be multiplied by reward level to calculate the payoff, and a binary choice task that involved choosing between high reward/high effort and low reward/low effort options. Model-free analyses in both tasks showed the same two effects when comparing unmedicated patients to medicated patients: dopamine depletion (1) decreased the amount of effort that patients were willing to produce for a given reward and (2) slowed down the production of this effort, regardless of reward level. Model-based analyses captured these effects with two independent parameters, namely reward sensitivity and motor activation rate. These two parameters were respectively predictive of medication effects on clinical measures of apathy and motor dysfunction. More generally, we suggest that such computational phenotyping might help characterizing deficits and refining treatments in neuropsychiatric disorders.
Many neurological conditions are characterized by motor and motivational deficits, which both result in reduced behavior. It remains extremely difficult to disentangle whether these patients are simply unable or do not want to produce a behavior. Here, we propose a model-based analysis of the behavior produced in tasks that involve trading physical efforts for monetary rewards, to quantify parameters that capture motor dynamics as well as sensitivity to reward, effort, and fatigue. Applied to Parkinson's disease, this computational analysis revealed two independent effects of dopamine enhancers, which predicted clinical improvement in motor and motivational deficits. Such computational profiling might provide a useful explanatory level, between neural dysfunction and clinical manifestations, for characterizing neuropsychiatric disorders and personalizing treatments.
运动功能障碍(如运动迟缓)和动机缺乏(即冷漠)是帕金森病(PD)的典型特征。然而,这两种症状是否源于相同的多巴胺能功能障碍仍不清楚。在此,我们开发了一种计算模型,该模型将运动控制与经济决策理论相结合,以剖析多巴胺在人类中的运动和动机功能。该模型可以捕捉行为的不同方面:选择(选择哪种行动)和活力(行动速度和强度)。它被用于描述24名PD患者在两种行为任务中的行为特征,这两种任务分别在服药和未服药时进行测试:一种激励动机任务,即付出体力努力,知道该努力会乘以奖励水平来计算收益;另一种二元选择任务,即在高奖励/高努力和低奖励/低努力选项之间进行选择。在这两项任务中,与服药患者相比,未服药患者的无模型分析显示出相同的两种效应:多巴胺耗竭(1)降低了患者为给定奖励愿意付出的努力量,(2)减缓了这种努力的产生,无论奖励水平如何。基于模型的分析用两个独立参数捕捉了这些效应,即奖励敏感性和运动激活率。这两个参数分别预测了药物对冷漠和运动功能障碍临床指标的影响。更一般地说,我们认为这种计算表型分析可能有助于在神经精神疾病中表征缺陷并优化治疗。
许多神经系统疾病的特征是运动和动机缺乏,这两者都会导致行为减少。要弄清楚这些患者是根本无法还是不想产生某种行为仍然极其困难。在此,我们提出一种基于模型的分析方法,用于分析在涉及用体力努力换取金钱奖励的任务中产生的行为,以量化捕捉运动动态以及对奖励、努力和疲劳敏感性的参数。应用于帕金森病时,这种计算分析揭示了多巴胺增强剂的两种独立效应,这两种效应预测了运动和动机缺乏的临床改善。这种计算分析可能在神经功能障碍和临床表现之间提供一个有用的解释层面,用于表征神经精神疾病并实现个性化治疗。